EyePoint, Inc. Debt Securities, Available-for-sale, Current
EyePoint, Inc. (EYPT) had Debt Securities, Available-for-sale, Current of $33.00 million as of 2021-12-31, per its 10-K filed 2022-03-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2022-03-14
- 2021-12-31: Debt Securities, Available-for-sale, Current $33.00M.
- 2020-12-31: Debt Securities, Available-for-sale, Current $0.00.
| Period end | Debt Securities, Available-for-sale, Current |
|---|---|
| 2021-12-31 | $33.00M 10-K · filed 2022-03-14 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |